Clinical evaluation of the use of infracyanine green staining for internal limiting membrane peeling in epimacular membrane surgery

European Journal of Ophthalmology

Volumn 18, Issue 6, 2008, Pages 972-979

  Feldman, A ^a   Zerbib, J ^a   Glacet Bernard, Agnes ^a   Haymann, P ^a   Soubrane, G ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Epiretinal membrane; Indocyanine green; Infracyanine green; Optic nerve fiber layer; Vitreomacular surgery

Indexed keywords

DYE; INFRACYANINE GREEN; UNCLASSIFIED DRUG; COLORING AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDOCYANINE GREEN;

AGED; ARTICLE; CONTROLLED STUDY; EPIRETINAL MEMBRANE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE LESION; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA HOLE; STAINING; SURGICAL TECHNIQUE; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY; BASEMENT MEMBRANE; COMPARATIVE STUDY; ELECTRORETINOGRAPHY; EVALUATION; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RETINA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL FIELD;

AGED; BASEMENT MEMBRANE; COLORING AGENTS; ELECTRORETINOGRAPHY; EPIRETINAL MEMBRANE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INTRAOPERATIVE COMPLICATIONS; PERIMETRY; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETINA; RETROSPECTIVE STUDIES; STAINING AND LABELING; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS;

EID: 58149401461     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800619     Document Type: Article

References (34)

1. Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and association of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 1997; 104: 1033-40.
2. Margherio RR, Cox MS Jr, Trese MT, Murphy PL, Johnson J, Minor LA. Removal of epiretinal membranes. Ophthalmology 1985, 92: 1075-83.
3. Wilkinson CP. Recurrent macular pucker. Am J Ophthalmol 1979; 88: 1029-31.
4. Park DW, Dugel PU, Garda J, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology 2003; 110: 62-14.
5. Bovey EH, Uffer S, Achache F. Surgery for epimacular membrane: impact of retinal internal limiting membrane removal on functional outcome. Retina 2004; 24: 728-35.
6. Kampik A, Green WR, Michels RG, Nase PK. Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980; 90: 797-809.
7. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol 1981; 99: 1445-54.
8. Husson-Danan A, Glacet-Bernard A, Soubrane G, Coscas G. Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery. Graefes Arch Clin Exp Ophthalmol 2006; 244: 291-7.
9. Stalmans P, Van Aken EH, Veckeneer M, Feron EJ, Stalmans I. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 2002; 134: 282-5.
10. Foulquier S, Glacet-Bernard A, Sterkers M, Soubrane G, Coscas G. Study of internal limiting membrane peeling in stage 3 and 4 idiopathic macular hole surgery. J Fr Ophtalmol 2002; 25: 1026-31.
11. Hillenkamp J, Saikia P, Gora F, et al. Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green. Br J Ophthalmol 2005; 89: 437-43.
12. Da Mata AP, Burk SE, Riemann CID, et al. Indocyanine-green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001; 108: 1187-92.
13. Weinberger AW, Schlossmacher B, Dahlke C, Hermel M, Kirchhof B, Schrage NF. Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery: a follow-up study. Graefes Arch Clin Exp Ophthalmol 2002; 240: 913-7.
14. Kwok AK, Lai TY, Man-Chan W, Woo DC. Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 2003; 87: 71-4.
15. Kwok AK, Lai TY, Li WY, Woo CF, Chan RC. Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol 2004; 138: 194-9.
16. Haritoglou C, Gandorfer A, Gass CA, Sdhaumberger M, Ulbig MW, Kampik A. The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 2003; 135: 328-37.
17. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002; 134: 836-41.
18. Ando F, Sasano K, Ohba N, Hirose H, Yasui O. Anatomic and visual outcomes after indocyanine grebn-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 2004; 137: 609-14.
19. Haritoglou C, Gandorfer A, Schaumberger M, Tadayoni R, Gandorfer A, Kampik A. Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium. Invest Ophthalmol Vis Sci 2003; 44: 2722-9.
20. Gandorfer A, Haritoglou C, Gandorfer A, Kampik A. Retinal damage from Indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003; 44: 316-23.
21. Ikagawa H, Yoneda M, Iwaki M, et al. Chemical toxicity of indocyanine green damages retinal pigment epithelium. Invest Ophthalmol Vis Sci 2005; 46: 2531-9.
22. Paques M, Genevois O, Regnier A, et al. Axon-tracing properties of indocyanine green. Arch Ophthalmol 2003; 121: 367-70.
23. Jackson TL, Vote B, Knight CK, El-Amir A, Stanford MR, Marshall J. Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004; 45: 3697-703.
24. Kodjikian L, Richter T, Halberstadt M, et al. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol 2005; 243; 917-25.
25. Lai TY, Kwok AK, Au AW, Lam DS. Assesment of macular function by multifolcal electroretinography following epiretinal membrane surgery with indocyanine green-assisted internal limiting membrane peeling. Graefes Arch Clin Exp Opthalmol 2007; 245: 148-54.
26. Kadonosono K, Yamakawa T, Uchio E, Yanagi Y, Tamaki Y, Araie M. Comparison of visual function after epiretinal membrane removal by 20-gauge and 25-gauge vitrectomy. Am J Ophthalmol 2006; 142: 513-5.
27. Suami M, Mizota A, Hotta Y, Tanaka M. Pattern VEPs before and after idiopathic epiretinal membrane removal. Doc Ophthalmol 2007; 114: 67-73.
28. Ullern M, Roman S, Dhalluin JF, et al. Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery. J Fr Ophtalmol 2002; 25: 915-20.
29. Uemura A, Kanda S, Sakamoto Y, Kita H. Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2003; 136: 252-7.
30. Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, Kitaoka T. Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2007; 143: 704-5.
31. Welch JC. Dehydration injury as a possible cause of visual field defect after pars plana vitrectomy for macular hole. Am J Ophthalmol 1997; 124: 698-9.
32. Ohji M, Nao-I N, Saito Y, Hayashi A, Tano Y. Prevention of visual field defect after macular hole surgery by passing air used for fluid-air exchange through water. Am J Ophthalmol 1999; 127: 62-6.
33. Yoshida M, Kishi S. Pathogenesis of macular hole recurrence and its prevention by internal limiting membrane peeling. Retina 2007; 27: 169-73.
34. Do DV, Cho M, Nguyen QD, et al. Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction. Retina 2007; 27: 552-6.